Subscribe to our Newsletters !!

    Coronavirus vaccine

    Chinese firm Sinovac 99% sure COVID-19 antibody will work: Report

    Chinese biopharmaceutical organization Sinovac Biotech has said that it is 99% certain that their COVID-19 antibody will work. The organization arrived at stage 2 of the coronavirus antibody preliminary with in excess of 1000 volunteers taking part. The organization is in starter converses with hold stage 3 preliminaries – the last piece of the procedure

    Researchers create technique to assist disease transmission experts with mapping spread of COVID-19

    Rochester Institute of Technology researchers have built up a strategy they accept will help disease transmission specialists all the more proficiently foresee the spread of the COVID-19 pandemic. Their new examination, distributed in Physica D: Nonlinear Phenomena, diagrams an answer for the SIR pandemic model, which is regularly used to anticipate what number of individuals

    Russia to reveal its previously endorsed COVID-19 drug one week from now

    Russia will begin giving its first medication affirmed to treat COVID-19 to patients one week from now, its state money related benefactor told Reuters, a move it expectations will ease strains on the wellbeing framework and speed an arrival to typical monetary life. Russian clinics can start giving the antiviral medication, which is enlisted under

    Brazil eyes Covid antibody rollout in January: Minister

    Brazil’s acting Health Minister Eduardo Pazuello stated on Tuesday that a COVID-19 vaccine could be rolled out for all Brazilians in January 2021. “We’re closing contracts with vaccine manufacturers and the forecast is that a vaccine will arrive for us starting in January next year and we will begin vaccinating everybody,” Eduardo Pazuello said in

    Vaccines may require regular updates as Covid develops, say researchers

    A health worker checks the Covishied, a COVID-19 vaccine manufactured by Serum Institute of India, as she prepares to start vaccination against COVID-19 in Kathmandu, Nepal January 27, 2021. (Reuters/Navesh Chitrakar) Scientists have assessed the course of development of the novel coronavirus and predicted that COVID-19 vaccines currently in use across the world may need

    Pfizer starts investigation of oral drug for counteraction of COVID-19

    Pfizer Inc said on Monday it has started a mid-to-late-stage study testing its investigational oral antiviral drug for the prevention of COVID-19 infection among those who have been exposed to the virus. The company and its rivals, including U.S.-based Merck & Co Inc and Swiss pharmaceutical Roche Holding AG, have been racing to develop the